Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service has participated in 1 clinical trials.
Therapeutic areas: Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.
Sponsors: Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service has 1 clinical trials on record. Their work covers Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.
Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.